|
Even in well-maintained water systems, time and again OOS/OOT results
in microbiological monitoring will occur suddenly and only for a
short period. If the organisms found are typical water germs, in most
cases biofilms in the plant are the cause.
Due to the strict microbiological requirements on water
for pharmaceutical use and the high risks represented by the microbial
contamination of water, the pharmaceutical industry makes great efforts
to prevent microbial growth in water systems.
In this context the danger involved in biofilms is
often underestimated. Sanitisation measures are often
aimed at single mobile bacteria. These can be found in the
high-purity and thus scarcely nourishing waters of the pharmaceutical
industry, like water for injection - however, in very small numbers. For
energetic reasons, the low-concentrated nutrients, which come from the
feed water, adhere to the surfaces e.g. of water pipes. This is also
where the bacteria can attach themselves and proliferate. Another
promotive effect is the low flow velocity on the pipe surfaces, which
even tends towards zero in laminar flow and can hardly rinse the
microbes off the pipes.
In the growing biofilm, the germs show a different behaviour
than when floating free. They produce a polysaccharide, which both forms a
protective layer over the bacteria in the biofilm and serves to "catch" further
nutrients from the water. Within this protective layer, the germs are
characterised by a markedly elevated resistance against heat,
disinfectants and dehydration than in the free state. This is why bacteria in
biofilms can survive sanitisation measures. But even if all cells within the
film are killed, the amalgamation of cells and polysaccharide remaining on the
surface offer an ideal medium to further bacteria entering the water system
sporadically with the feed water. Both living and dead biofilms represent a
danger to the pharmaceutical end product. On the one hand, living bacteria or
parts of the biofilm compound come off the surface from time to time and are
thus a microbiological contamination source. On the other hand, dead
biofilm fragments, too, represent a contamination source of endotoxins.
The battle against biofilms still remains a major
challenge to the pharmaceutical industry. It is crucial to find suitable
measures for the water system in question and to implement them
consequently, e.g. hot storage, sanitisation with steam and ozone. In
addition, as early as in the design stage, taking account of an
appropriate surface treatment and a sufficiently turbulent flow can help
to prevent the creation of biofilm during the operation of the water
system.
Author:
Dr Robert Eicher
On behalf of the European Compliance Academy (ECA)
|